Ryne Sandberg

Ryne Sandberg opines on baseball’s steroid era

45 Comments

Phillies third base coach Ryne Sandberg is expected to be the next Phillies manager if and when the Charlie Manuel era ends. Sandberg started his playing career with the Phillies but went to the Cubs in the infamous Ivan de Jesus trade in 1982, arguably one of the worst trades in baseball history. With the Cubs, Sandberg would become one of the best second basemen ever to play the game. In recent years, he has worked his way up through the Minor Leagues as a coach.

MLB.com’s Barry M. Bloom peppered Sandberg with questions about his past when he managed in the Minor Leagues, what he expects in the future, and got Sandberg to opine on how the Hall of Fame should handle players from the steroid era.

Sandberg: I’m not a sportswriter. I don’t get to vote. I don’t get the ballot in the mail, so it’s out of my hands either way. I can say that in the history of the Hall of Fame, there are no suspicions about guys who are in the Hall of Fame. It’s an elite group. And once you’re in the Hall, you’re in the Hall. Up until now, I think the voting system has handled things very well. And like I said before, there are no suspicions in the Hall of Fame.

MLB.com: But in your speech, you did say that Andre Dawson should be in. You said, “He did it the right way, the natural way.” So you have voiced your opinion, even though you don’t have a vote.

Sandberg: But that wasn’t about drugs. That was about a player whose numbers, I thought, were being dwarfed by those put up in that era. I played with the guy and against him for most of my career. I saw most of his career. For a number of years, he was overshadowed by the guys who hit 60 or 70 home runs. Those numbers were astronomical and were numbers I could not relate to. I thought he was a Hall of Famer and had had a Hall of Fame career. That’s why I voiced my opinion on that, and I was very happy to see him go in.

Sandberg isn’t 100% right about there being “no suspicions in the Hall of Fame”. The Hall is rife with bat-corkers, ball-scuffers, spitballers, players who have taken amphetamines (e.g. Willie Mays, Hank Aaron, Mike Schmidt), and so forth. Not to mention the otherwise unsavory characters like Ty Cobb.

Older eras of baseball were just as impure as the steroid era has been purported to be. You see this a lot when older people talk about the younger generations. Take TIME Magazine’s latest cover, for instance, titled “The ME ME ME Generation”. Or their 1990 cover titled “twentysomething”, asking if the generation is “laid back, late blooming, or just lost?” People tend to romanticize the generation in which they were brought up and demonize ensuing generations. It seems like that’s what Sandberg is doing here, willfully glossing over his own generation’s seedy history to complain about those damn kids with their loud music and their steroids.

Nick Cafardo: Red Sox should deal Pomeranz, not Buchholz

BOSTON, MA - SEPTEMBER 18: Drew Pomeranz #31 of the Boston Red Sox pitches during the first inning against the New York Yankees at Fenway Park on September 18, 2016 in Boston, Massachusetts. The Red Sox won 5-4. (Photo by Rich Gagnon/Getty Images)
Getty Images
4 Comments

The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.

The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.

Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.

Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.

Report: Arquimedes Caminero likely to sign with Yomiuri Giants

SEATTLE, WA - AUGUST 21: Arquimedes Caminero #48 of the Seattle Mariners delivers a pitch during a game against the Milwaukee Brewers at Safeco Field on August 21, 2016 in Seattle, Washington. The Brewers won the game 7-6. (Photo by Stephen Brashear/Getty Images)
Getty Images
Leave a comment

Mariners’ right-hander Arquimedes Caminero is nearing a deal with the Yomiuri Giants of Nippon Professional Baseball, according to Bob Dutton of the Tacoma News Tribune. The club has reportedly agreed to sell the 29-year-old’s contract, Dutton writes, though no official move has been announced by either team yet. Caminero is under club control through 2020 and currently ineligible for arbitration.

The right-hander began the 2016 season with the Pirates but was sent to the Mariners in a trade for Seattle minor leaguers Jake Brentz and Pedro Vasquez in order to clear space in the Bucs’ bullpen. With the Mariners, Caminero produced a 3.66 ERA and 8.2 K/9 through 19 2/3 innings in the second half of the year. Although he boasts an electric fastball, one which consistently averaged 98.7 m.p.h. in 2016, his success rate has been tempered by poor control throughout his major league career. According to Dutton, the Mariners’ willingness to sell Caminero’s contract was a strong indication that they did not see him as a viable contender for their 2017 bullpen or as a potential trade chip further down the line.

Should the deal go through, the right-hander will be the second former Mariner to sign with a Japanese club for the 2017 season. Per Dutton’s report, outfielder Stefen Romero also picked up a contract with the Orix Buffaloes of NPB in late November.